Back to Search
HARVEY VALDEZ, D.M.D.
D.M.D.
General Practice Dentistry
NPI: 1548325491Individual
Specialties, Licenses & Credentials
General Practice DentistryPrimary
Dentist — General Practice
Code: 1223G0001X
DN 10403(FL)
Research & Publications (20)
Accessory cell dependent NK cell mediated PBMC IFN-gamma production is defective in HIV infection.
PMID 19196551·Clin Immunol·2009
8-other
Concurrent use of statins does not influence efficacy of maraviroc in Maraviroc versus Optimized Therapy in Viremic Antiretroviral Treatment-Experienced Patients 1 and 2 trials.
PMID 19622911·AIDS·2009
8-other
Drug toxicity, HIV progression, or comorbidity of aging: does tipranavir use increase the risk of intracranial hemorrhage?
PMID 18831696·Clin Infect Dis·2008
8-other
Role of the N-terminal starch-binding domains in the kinetic properties of starch synthase III from Arabidopsis thaliana.
PMID 18260645·Biochemistry·2008
8-other
Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: implications for cardiovascular risk.
PMID 18431498·PLoS One·2008
2-rct
Functional and structural characterization of the catalytic domain of the starch synthase III from Arabidopsis thaliana.
PMID 17623838·Proteins·2008
8-other
Treatment response to ritonavir-boosted tipranavir versus ritonavir-boosted lopinavir in HIV-1 patients with higher lopinavir mutation scores.
PMID 18090054·AIDS·2007
4-observational
Steady-state disposition of the nonpeptidic protease inhibitor tipranavir when coadministered with ritonavir.
PMID 17485497·Antimicrob Agents Chemother·2007
3-trial
Statins Blunt HAART-Induced CD4 T-Cell Gains but Have No Long-Term Effect on Virologic Response to HAART.
PMID 17579125·J Int Assoc Physicians AIDS Care (Chic)·2007
8-other
Antiviral activity of low-dose alovudine in antiretroviral-experienced patients: results from a 4-week randomized, double-blind, placebo-controlled dose-ranging trial.
PMID 17461857·HIV Med·2007
2-rct
Long-term efficacy and safety of tipranavir boosted with ritonavir in HIV-1-infected patients failing multiple protease inhibitor regimens: 80-week data from a phase 2 study.
PMID 17554217·J Acquir Immune Defic Syndr·2007
3-trial
Deficiency of Arabidopsis thaliana frataxin alters activity of mitochondrial Fe-S proteins and induces oxidative stress.
PMID 17092311·Plant J·2006
8-other
A pilot study evaluating time to CD4 T-cell count <350 cells/mm(3) after treatment interruption following antiretroviral therapy +/- interleukin 2: results of ACTG A5102.
PMID 16760795·J Acquir Immune Defic Syndr·2006
2-rct
Gender differences in human immunodeficiency virus (HIV) RNA and CD4 cell counts among new entrants to HIV care.
PMID 16524417·Clin Microbiol Infect·2006
4-observational
Cyclosporin A provides no sustained immunologic benefit to persons with chronic HIV-1 infection starting suppressive antiretroviral therapy: results of a randomized, controlled trial of the AIDS Clinical Trials Group A5138.
PMID 17109339·J Infect Dis·2006
3-trial
Differential effect of interleukin-2 treatment on primary and secondary immunizations in HIV infected individuals.
PMID 16260902·AIDS·2005
8-other
New entrants to HIV care are presenting only at marginally earlier stages of disease but may increasingly represent groups perceived at lower risk.
PMID 16103026·J Int Assoc Physicians AIDS Care (Chic)·2005
8-other
A 14-day dose-response study of the efficacy, safety, and pharmacokinetics of the nonpeptidic protease inhibitor tipranavir in treatment-naive HIV-1-infected patients.
PMID 15097154·J Acquir Immune Defic Syndr·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 508 N MARYLAND AVE
PLANT CITY, FL 33563 - Phone
- (813) 349-7600
Quick Facts
- NPI
- 1548325491
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile